Zimbabwe has rejected a $367 million five-year health aid package from the United States, citing concerns over data sovereignty and what the government describes as a “lopsided” agreement demanding access to sensitive citizen data. The decision, revealed after a leaked December government memo, threatens to disrupt critical health programs, particularly those addressing HIV/AIDS, tuberculosis, and malaria.
According to a statement from U.S. Ambassador to Zimbabwe, Pamela Tremont, the United States will now begin “winding down” its health assistance programs in the country. The U.S. Embassy confirmed that over the past two decades, Washington has provided more than $1.9 billion in health funding to Zimbabwe.
The core of the dispute lies in the U.S. Government’s requirement for access to biological samples and epidemiological information from Zimbabwean citizens for research purposes, with limited guarantees of reciprocal benefits. Zimbabwean officials argue that the U.S. Sought “comprehensive access” to health data without a corresponding commitment to share any resulting medical innovations, such as vaccines or treatments, with Zimbabwe. President Emmerson Mnangagwa reportedly directed that negotiations be terminated over this issue.
Government spokesperson Nick Mangwana stated that the U.S. Proposal was unacceptable due to concerns about fairness, sovereignty, and a broader shift in U.S. Foreign policy. He emphasized that Zimbabwe could not accept conditions that compromised the nation’s control over its citizens’ health data.
The rejection of the aid package follows a similar situation in Kenya in December, where the High Court suspended a health funding agreement with the U.S. After a consumer rights lobby raised concerns about the safety of Kenyans’ health data. This suggests a potential pattern of resistance to U.S. Data demands within the region.
The move comes as U.S. President Donald Trump has pursued a policy of reducing foreign aid and shifting away from traditional aid agencies like USAID, favoring direct government-to-government deals intended to increase transparency and accountability. However, critics argue this approach has led to more stringent conditions and reduced funding overall.
Zimbabwean doctors have expressed concern over the potential impact of the funding withdrawal on the country’s already strained health system. A doctors’ association has called for renewed dialogue to reach a mutually acceptable agreement that would ensure the continuation of vital HIV programs and other essential health services. The loss of U.S. Funding casts uncertainty over programs to combat HIV and the public health sector in one of the world’s most vulnerable health systems, where patients often must supply even basic items such as bandages at clinics and often have to buy their own medicines due to shortfalls.
As of Wednesday, the U.S. Government has not indicated any intention to revisit the terms of the agreement, leaving the future of health assistance to Zimbabwe uncertain.
